РезурокБеломосудил200 mgthirtyТабGeneric Rezurock (belumosudil) is indicated for treating adult and pediatric patients 12 years and older with chronic graft-versus-host disease (chronic GVHD) after the failure of at least two prior lines of systemic therapy.
Rezurock (belumosudil) is indicated for treating adult and pediatric patients 12 years and older with chronic graft-versus-host disease (chronic GVHD) after the failure of at least two prior lines of systemic therapy.
